Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of October 19, 2025

By / October 22, 2025

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

TRUQAP (capivasertib)

Astrazeneca Patent: 8,809,336 Expiration: Oct 25, 2025

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

The Pharmaceutical Patent Fortress: A Strategic…
A Strategic Guide to Risk Mitigation in Drug…
Competitive Intelligence in Excipients: How to Know…
How to Spot Formulation Switch Opportunities Before…
The Gold in the Second Act: A Strategic Guide to…
Building Your Excipient Roadmap: Using NDC…
The Hidden Variable: Turning Excipient Awareness…
Global Perspectives: A Strategic Analysis of the…
Leveraging Tentative Generic Approvals for…
The Rise of Telehealth Companies Like Ro and Hims…
The Russian Pharmaceutical Industry: A Definitive…
The New Pharma Playbook: A 2025-2030 Guide to Market…
Drug APIs Start Here: How to Nail Your KSM Strategy
The Patent Cliff and Beyond: A Definitive Guide to…
Deconstructing Lifecycle Management and Filing…
The Patent Cliff's Shadow: Impact on Branded…
The Patent Playbook for Pharma: Protect Your Drug.…
The Art of the Second Act: A Six-Step Framework for…
Inside the Russian Pharma Industry: Key Players and…
The Missing Ingredient: Why Patent Data Is the Key…
Drug Repositioning: One Molecule. Two Indications.…
Effective Drug Patent Prosecution Strategies:…
The Crystal Ball of Pharma: Using Patent Expiry Data…
A Definitive Guide to Valuing Pharmaceutical and…

The Price of a Miracle: A Strategic Blueprint for Optimal Pharmaceutical Launch Pricing

The First-Filer’s Playbook: 10 Critical Steps to De-Risk and Dominate with a Paragraph IV Filing

Related Posts

Drug Patent Expirations for the Week of August 10, 2025

Patent Expiration / By

Drug Patent Expirations for the Week of August 17, 2025

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

The Generic’s Gauntlet: A Strategic Playbook for ANDA Filing and Market Domination
From Chaos to Calculation: A Comprehensive Report on Algorithmic Drug Portfolio Optimization
The AI Revolution in Drug Repurposing: A Comprehensive Pipeline Analysis from Target Identification to Clinical and Commercial Validation
How Financial Analysts Use Drug Patent Expiry Data to Predict Pharma Stock Movements
The Myth of the “Clean” Patent Expiry in Pharmaceuticals: Strategic Analysis of Loss of Exclusivity, Patent Thickets, and Market Entry Dynamics

Popular Posts

A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
The Pharmaceutical Gambit: An Analysis of Why India Lags China and a Roadmap to Competitive Parity
Valuation of Pharmaceutical Companies: A Comprehensive Analysis of Key Considerations
The Rise of Telehealth Companies Like Ro and Hims & Hers: How Direct-to-Consumer Telehealth Redefined the Pharmaceutical Value Chain
Top 6 issues facing the biotechnology industry
The New Pharma Playbook: A 2025-2030 Guide to Market Domination in a Data-Driven World
How Long Does a Patent Last for Drugs? A Comprehensive Guide to Pharmaceutical Patent Duration
The Myth of the “Clean” Patent Expiry in Pharmaceuticals: Strategic Analysis of Loss of Exclusivity, Patent Thickets, and Market Entry Dynamics
The Role of China in the Global Generic Drug API Market
Comprehensive Guide to Pharmaceutical Portfolio Management: Essential Reading Resources

Copyright © 2025 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested

Last Updated on October 22, 2025 by